CVE-2022-48224 describes an insecure permissions vulnerability in the Acuant AcuFill SDK prior to version 10.22.02.03, affecting gbgplc acuant_acufill_sdk. This flaw allows standard users to replace executable files within the SDK's installation directory, which are then run with elevated privileges. With a CVSS score of 7.3 (High), this local privilege escalation vulnerability enables arbitrary code execution with high impact on confidentiality, integrity, and availability. There is currently no evidence of active exploitation, public exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion or media coverage surrounding this CVE.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
< 10.22.02.03CPE matchmatch criteria | cpe:2.3:a:gbgplc:acuant_acufill_sdk:*:*:*:*:*:*:*:* |
CVSS version used by this source: 3.1
CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H
The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.1 Bluesky, 0.0 Mastodon, and 0.1 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.2 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.